Galapagos NV's Other Investors

Galapagos NV raised a round of funding on , .

Galapagos is a clinical stage biotech company focused on developing novel medicines. Galapagos' most advanced candidate drug GLPG0634 shows excellent safety and efficacy in rheumatoid arthritis patien…

Articles about Galapagos NV's Other Investors: